Inflammatory biomarkers, glycemic variability, hypoglycemia, and renal transplant outcomes: Results of a randomized controlled trial

Transplantation

Volumn 98, Issue 6, 2014, Pages 632-639

  Li, Ping ^a,b   Hunt, Kelly J ^a   Taber, David J ^a   Carter, Rickey E ^c   Kettinger, Lindsey ^a   Luttrell, Deirdre ^a   Egidi, Maria F ^d   Finch, Nancy J ^a   Baliga, Prabhakar ^a   Lin, Angello ^a   Biggins, Shari ^a   Hermayer, Kathie L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NANJING UNIVERSITY   (China)

^c MAYO CLINIC   (United States)

^d UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Acute allograft rejection; Blood glucose; Glycemic variability; Hypoglycemia; Inflammatory biomarkers; Renal transplantation

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; GLUCOSE BLOOD LEVEL; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; FEMALE; GLYCEMIC CONTROL; GLYCEMIC VARIABILITY; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PHYSICAL PARAMETERS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; TREATMENT RESPONSE; AGED; ANALYSIS; BLOOD; COHORT ANALYSIS; GLUCOSE BLOOD LEVEL; INFLAMMATION; METABOLISM; RENAL INSUFFICIENCY; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; GRAFT REJECTION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; RISK FACTORS; TREATMENT OUTCOME;

EID: 84922481571     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000123     Document Type: Article

References (26)

1. Burrows NR, Li YF, Geiss LS. Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline. Diabetes Care 2010; 33: 73.
2. US Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: US Renal Data System; 2010.
3. Guerra G, Ilahe A, Ciancio G. Diabetes and kidney transplantation: past, present, and future. Curr Diab Rep 2012; 12: 597.
4. Rangel EB, de Sá JR,Melaragno CS, et al. Kidney transplant in diabetic patients: modalities, indications and results. Diabetol Metab Syndr 2009; 1: 2.
5. Parekh J, Bostrom A, Feng S. Diabetes mellitus: a risk factor for delayed graft function after deceased donor kidney transplantation. Am J Transplant 2010; 10: 298.
6. Hermayer KL, Egidi MF, Finch NJ, et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. J Clin Endocrinol Metab 2012; 97: 4399.
7. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180: 821.
8. Arabi YM, Tamim HM, Rishu AH. Hypoglycemia with intensive insulin therapy in critically ill patients: predisposing factors and association with mortality. Crit Care Med 2009; 37: 2536.
9. Eslami S, Taherzadeh Z, Schultz MJ, et al. Glucose variability measures and their effect on mortality: a systematic review. Intensive Care Med 2011; 37: 583.
10. Egi M, Bellomo R, Stachowski E, et al. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105: 244.
11. Dandona P, Alijada A, Bandyopadhyay A. The potential therapeutic role of insulin in acute myocardial infarction in patients admitted to intensive care and in those with unspecified hyperglycemia. Diabetes Care 2003; 26: 516.
12. Dahle DO, Mjøen G, Oqvist B, et al. Inflammation-associated graft loss in renal transplant recipients. Nephrol Dial Transplant 2011; 26: 3756.
13. Perez RV, Brown DJ, Katznelson SA, et al. Pretransplant systemic inflammation and acute rejection after renal transplantation. Transplantation 2000; 15: 869.
14. Roshdy A, EI-Khatib MM, Rizk MN, et al. CRP and acute renal rejection: a marker to the point. Int Urol Nephrol 2012; 44: 1251.
15. Thomas MC,Mathew TH, Russ GR, et al. Early perioperative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation 2001; 72: 1321.
16. Troppman C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation 1995; 59: 962.
17. Marfella R, Di Filippo C, Portoghese M, et al. Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. J Am Coll Cardiol 2009; 53: 1425.
18. Hansen TK, Thiel S, Wouters PJ, et al. Intensive insulin therapy exerts anti-inflammatory effects in critically patients and counteracts the adverse effects of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003; 88: 1082.
19. Liang SL, ClarkeW. Urine proteomic profiling for biomarkers of acute renal transplant rejection. Methods Mol Biol 2010; 641: 185.
20. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007; 35: 2262.
21. Hermanides J, Bosman RJ, Vriesendorp TM, et al. Hypoglycemia is associated with intensive care unitmortality. Crit CareMed 2010; 38: 1430.
22. Egi M, Bellomo R, Stachowski E, et al. Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc 2010; 85: 217.
23. Razavi Nematollahi L, Kitabchi AE, Stentz FB, et al. Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism 2009; 58: 443.
24. Trovati M, Anfossi G, Cavalot F, et al. Studies on mechanisms involved in hypoglycemia-induced platelet activation. Diabetes 1986; 35: 818.
25. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008; 36: 3008.
26. Meyfroidt G, Keenan DM, Wang X, et al. Dynamic characteristics of blood glucose tome series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med 2010; 38: 1021.